year
111Category: | Intermediates/Pharmaceutical intermediates |
|
|
CAS NO: | 120202-66-6 | ||
EC NO: | |||
Molecular Formula: | C15H18ClNO6S2 | ||
Molecular Weight: | 419.8950 | ||
Specification: | |||
InChI: | InChI=1/C15H14ClNO2S.H2O4S/c16-12-4-2-1-3-11(12)14(15(18)19)17-7-5-13-10(9-17)6-8-20-13;1-5(2,3)4/h1-4,6,8,14H,5,7,9H2,(H,18,19);(H2,1,2,3,4)/t14-;/m0./s1 | ||
Product description: 17、Clopidogrel sulfate (Plavix) is an oral, thienopyridine class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease. Clopidogrel works by irreversibly inhibiting a receptor called P2Y12 CAS:120202-66-6 MF: C16H16ClNO2S.H2O4S MW:419.9 EINECS: Synonyms:PLAVIX;SR-25990C;CLOPIDOGREL SULFATE;CLOPIDOGREL SULPHATE;CLOPIDOGREL HYDROGEN SULPHATE;CLOPIDOGREL BISULPHATE;CLOPIDOGREL BISULFATE;d-Clopidogrel Properties Melting point:174-176°C storage temp. 2-8°C solubility DMSO: ~26 mg/mL form solid |
|||
Synonyms: | Clopidogrel bisulphate;clopidogrel hydrogen sulphate;clopidogrel sulphate;clopidogrel bisulfate;methyl (+)-(s)-a-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4h)acetate, hydrogen sulfate salt;(2S)-(2-chlorophenyl)(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)ethanoic acid sulfate (1:1);(+/-)-Clopidogrel bisulfate;Clopidogerl Bisulfate;Clopidogrel bisulphate /;Clopidogrel Bisulfate II;Clopidogrel Bisulfate I;Clopidogrel Bisulfate, FormI/FormII;Clopidogrel sulfate;Clopidogrel Hydrogensulfate; | ||
Molecular Structure: |